P/E at 61.19 vs Industry's 59.92: What the Data Shows for Apollo Hospitals Enterprise Ltd.

Valuation Picture: Premium Reflecting Sector Leadership?

The current P/E of 61.19 for Apollo Hospitals Enterprise Ltd. sits slightly above the hospital industry average of 59.92, indicating a valuation premium of approximately 2.2%. This premium suggests that investors are willing to pay a bit more for the stock relative to its peers, possibly reflecting expectations of superior earnings growth or operational resilience. However, the premium is not excessive, signalling a valuation that remains broadly in line with sector norms. The market capitalisation of Rs 1,11,240.44 crore firmly places the company in the large-cap category, underscoring its established position within the hospital sector.

Performance Across Timeframes: Mixed Signals

Examining the stock’s returns across multiple timeframes reveals a complex momentum profile. Over the past year, Apollo Hospitals Enterprise Ltd. has delivered a 10.53% gain, significantly outperforming the Sensex’s 3.87% loss during the same period. This outperformance extends to longer horizons, with three-year and five-year returns of 71.17% and 138.90% respectively, dwarfing the Sensex’s 26.30% and 55.09% gains. The ten-year return is particularly striking at 489.57%, more than doubling the Sensex’s 201.42% over the same period.

However, the short-term momentum is less consistent. The stock’s one-month return of 2.49% trails the Sensex’s 4.89%, while the one-day performance shows a slight decline of 0.19% against the Sensex’s 0.39% gain. Notably, the three-month return stands at a robust 13.73%, outperforming the Sensex’s negative 6.52%. This divergence between short-term and medium-term returns raises questions about the sustainability of recent gains — Apollo Hospitals Enterprise Ltd. has shown resilience, but is this momentum poised to continue or is it a temporary surge? What is the current rating?

Moving Average Configuration: Bullish Across All Key Levels

The technical picture for Apollo Hospitals Enterprise Ltd. is notably positive, with the stock trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This configuration typically signals a strong uptrend and suggests that the recent price action is supported by sustained buying interest. Being above all major moving averages indicates that the stock is not only in a recovery phase but also maintaining momentum over both short and long-term horizons. This technical strength contrasts with the slight underperformance seen in the one-day and one-month returns, highlighting the importance of monitoring intraday and monthly volatility within the broader uptrend.

Sector Context: Hospital Industry Performance

The hospital sector has experienced a mixed performance landscape recently, with a combination of positive, flat, and negative results across constituent stocks. Apollo Hospitals Enterprise Ltd. stands out as a large-cap leader, maintaining a valuation premium and outperforming the sector average in several timeframes. The sector’s average P/E of 59.92 reflects a generally elevated valuation environment, consistent with the healthcare industry's growth prospects and defensive qualities. Within this context, the stock’s premium is modest and appears justified by its consistent outperformance over the medium and long term.

Rating Reassessment: Previously Rated Hold

On 13 Apr 2026, the rating for Apollo Hospitals Enterprise Ltd. was updated from a previous Hold rating. The current Mojo Score stands at 75.0, reflecting a positive assessment across multiple parameters including fundamentals, technicals, and market sentiment. This reassessment aligns with the stock’s strong relative performance and technical positioning, although the valuation premium remains a factor for consideration. Should investors in Apollo Hospitals hold, buy more, or reconsider?

Summary: What the Data Collectively Shows

The data for Apollo Hospitals Enterprise Ltd. paints a picture of a large-cap hospital stock trading at a slight valuation premium relative to its sector. Its one-year and longer-term returns have outpaced the Sensex by a wide margin, underscoring its resilience and growth credentials. The technical setup is robust, with the stock positioned above all major moving averages, signalling sustained momentum. However, short-term returns show some volatility, with a minor dip in daily performance and a modest lag behind the Sensex over one month, suggesting investors should watch for potential fluctuations.

Overall, Apollo Hospitals Enterprise Ltd. remains a prominent player in the hospital sector with a valuation and performance profile that reflects its market stature. The reassessment from a previous Hold rating and the current Mojo Score of 75.0 indicate a positive shift in the stock’s analytical outlook. Investors should consider how the valuation premium aligns with the company’s growth trajectory and technical strength — is this the right time to adjust exposure to Apollo Hospitals?

Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today